There are 1076 resources available
698P - First-line aumolertinib in EGFR-mutant pulmonary adenosquamous carcinoma: Updated overall survival of the multicenter, single-arm, prospective study (ARISE)
Presenter: Long Zhang
Session: Poster Display session
Resources:
Abstract
699P - Osimertinib combined with chemotherapy as first-line treatment in EGFR-mutant advanced NSCLC patients: The first real-world analysis in China
Presenter: Wenxiang Ji
Session: Poster Display session
Resources:
Abstract
700P - Survival and efficacy of gefitinib plus chemotherapy versus gefitinib monotherapy on EGFR-mutant advanced non-small cell lung cancer: A systematic review and meta-analysis
Presenter: Kimberly Ismael
Session: Poster Display session
Resources:
Abstract
701P - Concordance of different immunohistochemical assays in MET protein overexpression detection in lung adenocarcinoma
Presenter: Li Liu
Session: Poster Display session
Resources:
Abstract
702P - Young and vulnerable: The alarming trends of lung cancer in young adults from India
Presenter: Pragadeesh Thamarai Selvan
Session: Poster Display session
Resources:
Abstract
703P - Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
Presenter: Yi Xiang
Session: Poster Display session
Resources:
Abstract
704P - Exploring the optimal tumour mutational burden (TMB) cutoff for predicting efficacy of immune checkpoint inhibitors (ICI) in Chinese patients with advanced non-small-cell lung cancer (NSCLC): A territory-wide study
Presenter: Victor Lee
Session: Poster Display session
Resources:
Abstract
705P - Exploring the Impact of DDR pathway gene mutations on the immune microenvironment in non-small cell lung cancer patients
Presenter: Canfeng Lin
Session: Poster Display session
Resources:
Abstract
706P - Comparison of irinotecan/carboplatin versus etoposide/carboplatin for extended disease small cell lung cancer (ED-SCLC): A systematic review and meta-analysis of randomized controlled trials
Presenter: Zeeshan Afzal
Session: Poster Display session
Resources:
Abstract
707P - Investigation of prognostic factors in extensive stage small cell lung cancer with immune checkpoint inhibitors in first-line treatment using real-world data: Are immune-related adverse events also a prognostic factor?
Presenter: Tadashi Nishimura
Session: Poster Display session
Resources:
Abstract